Larry Goldstein, PhD, Director, UCSD Stem Cell Program
Bio and Contact Info
Listen (3:16) Where are we at today with stem cell research?
Listen (5:14) One step beyond animal models
Listen (3:58) Why are stem cells so useful?
Listen (4:46) Promising applications for rare diseases
Listen (6:00) Funding has been a special challenge
Listen (3:22) Is there still a PR problem?
There are an estimated 7,000 rare or orphan diseases. But there are currently only treatments for about 5% of them. In this series, we've been exploring the promise of various new technologies to come up with more treatments and more cures. Today we are going to discuss the promising research with stem cells.
Scientists have made dramatic advances with stem cells over the past ten years. Dr. Larry Goldstein, Director of the Stem Cell Program at UCSD is one of them. He’s been using stem cells as a new technology for understanding disease, such as the rare Niemann Pick Type C disease. Stem cell therapy is now FDA approved for certain cancers and is at the heart of numerous clinical trials for various diseases.
Larry discusses the unique challenge that funding has proved for stem cell research and discusses whether there is still a PR problem holding back future research.
For more info, get the free eBook from Rare Genomics Institute
"Rare Disease Horizons: The Hope of New Research and Technology" is underwritten by the Rare Genomics Institute.